Biology News
Recro Pharma Announces Publication of Supportive Phase II IV Meloxicam Data in the Journal of Clinical Pharmacology - GlobeNewswire (press release)


GlobeNewswire (press release)
MALVERN, Pa., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today announced the publication of ...

Biocon, Sandoz partner for immunology and cancer biosimilars' development - Business Standard


Business Standard
Biocon has signed with Sandoz, the generics arm of the $48.52-billion Swiss Pharma giant Novartis to jointly invest and co-develop, manufacture and market, a new range of biosimilars in immunology and cancer for the global market. Both firms will have ...
The Center for Biosimilars
Moneycontrol.com
BioPharma Dive
 - -

Yukon has backlog of 20 deaths waiting for toxicology results - CBC.ca


CBC.ca
Toxicology reports can be requested in any case, and is required when there are questions as to the cause of death. One question about delays is whether they affect public health departments' abilities to understand the scope of epidemics, such as ...

Insight Pharma Reports

Needham, Massachusetts - United States

Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace.

Related
Insight Biotechnology Ltd.
United Kingdom

Supplier of thermostable DNA polymerases and restriction enzymes, antibodies and recombinant proteins from Wembley, England.

Eco Insight
United Kingdom

Eco Insight, in association with a network of specialists, provides a range of consulting services in the fields of ecology and conservation in Africa.

Molecular Insight Pharmaceuticals
United States

Molecular Insight is a clinical-stage biopharmaceutical company and a pioneer in the emerging field of molecular medicine. The Company is focused on the discovery, development, and commercialization of targeted radiotherapeutics and molecular imaging pharmaceuticals for use in oncology that are intended to improve the lives of patients through timely and accurate detection, improved treatment, and effective monitoring of therapeutic response and

Disease Insight Research Foundation
United States

DIRF is a non-profit foundation dedicated to conquering common diseases such as cancer or mental illness through genetic research.

New Disease Reports
United Kingdom

Electronic journal of the British Society for Plant Pathology, with content search, covering fungi, bacteria, phytoplasmas, viruses and viroids. Contains list of editors, author information, and related links.

Bioscience Reports
Germany

Articles related to cell surface function - including biochemical genetics, development, pharmacology, endocrinology, and immunology. Available online.

AM-Pharma BV.
Netherlands

Biopharmaceutical company focused on the therapeutic discovery, development and commercialisation, based on the innate human immune system. Corporate and technology overview, with key profiles and contacts in Bunnik, The Netherlands.

Germany

Topics are DNA replication, transcription, nucleic acid-protein interaction, RNA processing, intracellular transport, protein biosynthesis, and related subjects since 1997.

TransTech Pharma
United States

Translational technology platform translating genomic and proteomic data for small molecule therapeutics. Includes overview of methods, target therapies, careers and location at High Point, North Carolina.

Santaris Pharma
Denmark

Developing assays for disease-related microRNAs as therapeutic targets using miRNA antagonists technology.